Delivery Order SPE2DB20D1109-SPE2DB23FP64C

Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $724
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $44,630 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561723608 units of ketorolac 30 mg/ml vials to be delivered from its Conshohocken, Pennsylvania facility between August 7-8, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No subcontractors or set-aside designations...
The Defense Logistics Agency awarded a $1,273 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injections. Under this order, Amerisourcebergen will provide 4561598148 units of ketorolac 30 mg/ml vials to be delivered from its facility in Conshohocken, Pennsylvania. The order was awarded on July 25, 2023 and concludes on July 26, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's...
The Defense Logistics Agency awarded a $8,614 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561985300 units of ketorolac 30 mg/ml vials to the DLA from its facility in Conshohocken, Pennsylvania. The single day performance period of August 29-30, 2023 indicates this is likely a small urgent order to replenish inventory of this non-opioid pain medication supporting DLA medical supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $44,630 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4562319622 units of 30 mg/ml ketorolac vials to the DLA from its facility in Conshohocken, Pennsylvania under a one-day period of performance between September 26-27, 2023. The delivery order was issued against an existing DLA-managed contract vehicle, though details were not...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $647 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561813853 units of 15 mg/ml ketorolac vials to the DLA from its facility in Conshohocken, Pennsylvania under a one day period of performance spanning August 15-16, 2023. The delivery order was issued against an existing DLA-wide contract vehicle but no set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $462 to Amerisourcebergen Drug Corporation for ketorolac injectable medication. As the prime contractor, Amerisourcebergen will supply 4561667238 units of ketorolac 30 mg/ml vials to the DLA from its facility in Conshohocken, Pennsylvania. The single day order period is from August 1 to August 2, 2023. No subcontractors or set aside designations were specified. The DLA manages the global supply chain for the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $44,630 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4562232779 units of ketorolac 30 mg/ml vials from its Conshohocken, Pennsylvania facility for use by the Department of Defense. Performance will take place between September 19-20, 2023. The delivery order was issued under an existing DLA contract vehicle, though further details...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $48,450 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 456,166 units of 30 mg/ml ketorolac vials to the DLA for use in its medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. The delivery order was issued under the DLA's...
The Defense Logistics Agency awarded a $3,849 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561544275 units of 30 mg/ml ketorolac vials to the DLA for use in its medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. The parent company, Amerisourcebergen Corporation, will perform through...
The Defense Logistics Agency awarded a $96,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561611459 units of ketorolac 30 mg/ml vials from its Conshohocken, Pennsylvania facility. The single-day performance period of July 26-27, 2023 indicates this is a small quantity order to meet an immediate need, likely in support of the Department of Defense's medical readiness and...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP64C
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $724 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561653311 units of ketorolac 30 mg/ml vials from its facility in Conshohocken, Pennsylvania, with performance required between July 31 and August 1, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No subcontractors or set-aside designations were identified. The brief period of performance and pharmaceutical product ordered indicate this was likely an urgent order to replenish medical stock for DLA customers.

Generated 12/22/23, 4:17 PM